Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-09-02
1979-10-02
Waltz, Thomas
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260556A, 260556AC, 260557R, 260558R, 260561R, 424321, 424324, C07C10319, C07C14375, A61K 3116, A61K 3118
Patent
active
041698959
ABSTRACT:
N-alkylsulfonyl, N-alkanoyl and N-benzoyl 16,16-dimethyl-17-oxaprostaglandin E.sub.2 and E.sub.1 carboxamides having antisecretory biological activity as well as intermediates for their synthesis are disclosed.
REFERENCES:
patent: 3816393 (1974-06-01), Hayashi et al.
patent: 3927197 (1975-12-01), Monkhouse
patent: 3954741 (1976-05-01), Schaaf et al.
patent: 3981868 (1976-09-01), Bernady et al.
patent: 4060534 (1977-11-01), Bundy
patent: 4061671 (1977-12-01), Beck et al.
patent: 4098805 (1978-07-01), Bundy
patent: 4130584 (1978-12-01), Bundy
Collins et al., ". . . . Prostaglandins," Tetrahedron Letters, No. 48, pp. 4217-4220, 1975.
Hess Hans-Jurgen E.
Johnson Michael R.
Pfizer Inc.
Waltz Thomas
LandOfFree
Antisecretory 16,16-dimethyl-17-oxaprostaglandins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisecretory 16,16-dimethyl-17-oxaprostaglandins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisecretory 16,16-dimethyl-17-oxaprostaglandins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2369686